Every round on record, with the sources behind each and the investors on them.
A European evidence-based artificial intelligence platform for clinical knowledge and continuing medical education
dataimed.comLinkedInTurin, ItalyAIFounded 2024
3 sources · checked 20 times, last 23h ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
Source 3 describes €1.2 million as the total operation, including industrial and commercial support, and says it does not all represent paid-in capital. The capital-increase figure from Source 1 is used for the amount.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Operation | $1.3M €1.2 million | 2026-10-24 | not stated | No recent discussion |
3 sources · checked 20 times, last 23h ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 3 sources
Source 3 describes €1.2 million as the total operation, including industrial and commercial support, and says it does not all represent paid-in capital. The capital-increase figure from Source 1 is used for the amount. | ||||
DatAIMed builds a European AI platform that helps clinicians, researchers and healthcare organizations search and synthesize medical evidence, guidelines, drug data and internal documents with answers traceable to their sources.
DatAIMed is tackling the information overload and documentation burden that the company says make it difficult for healthcare professionals to find and apply reliable clinical knowledge quickly. Its €1.2 million operation, combining equity with industrial and commercial support and led by Maggioli, is intended to fund product, hiring and hospital-system integrations while the platform reports 15,000 registered healthcare professionals in Italy.
Checked against 10 sources yesterday